Prow Fusion device, based on the non-linear core technology, is designed for use during spinal fusion in transforaminal procedures.

Surgery was conducted in patients who were suffering from symptomatic degenerative disc disease with up to Grade I spondylolisthesis.

Prior to surgery, all patients underwent a regimen of at least six months of non-operative treatment without resolution of symptoms.

Results showed increase in quality of life of patients, safety of procedure as well as improved stability of disc height correction after insertion of Prow Fusion implant.

Maryland Scoliosis and Spine Center director Paul McAfee said the implant is designed to be delivered through a small incision, but is then deployed to provide a large footprint within the disc.

"It also provides for a substantial bone graft surface area for the interbody fusion," McAfee added.

NLT SPINE CEO Didier Toubia said the company has received positive feedback on the use of Prow Fusion and the results of the early clinical experiences have been good.

"As we prepare for the extended launch of the PROW FUSION system in early 2013, we are pleased to see it live up to its technological promise to improve patient care," Toubia added.